Prospera Financial Services Inc acquired a new position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 3,706 shares of the financial services provider’s stock, valued at approximately $359,000.
Several other large investors also recently bought and sold shares of IBB. JPMorgan Chase & Co. increased its holdings in iShares Nasdaq Biotechnology ETF by 120.0% in the second quarter. JPMorgan Chase & Co. now owns 1,108,069 shares of the financial services provider’s stock valued at $118,874,000 after buying an additional 604,388 shares in the last quarter. Tibra Equities Europe Ltd purchased a new position in iShares Nasdaq Biotechnology ETF during the second quarter worth about $58,914,000. Natixis boosted its stake in iShares Nasdaq Biotechnology ETF by 66.7% during the second quarter. Natixis now owns 1,250,929 shares of the financial services provider’s stock worth $136,476,000 after buying an additional 500,326 shares during the period. SG Americas Securities LLC purchased a new position in iShares Nasdaq Biotechnology ETF during the second quarter worth about $16,695,000. Finally, Advisory Services Network LLC boosted its stake in iShares Nasdaq Biotechnology ETF by 983.4% during the first quarter. Advisory Services Network LLC now owns 57,268 shares of the financial services provider’s stock worth $6,403,000 after buying an additional 51,982 shares during the period. Institutional investors and hedge funds own 77.82% of the company’s stock.
Shares of IBB traded up $0.62 during mid-day trading on Thursday, hitting $105.06. 394,977 shares of the company’s stock were exchanged, compared to its average volume of 1,932,403. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $89.01 and a fifty-two week high of $122.97. The stock’s 50-day moving average is $103.96 and its 200-day moving average is $106.63.
iShares Nasdaq Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Further Reading: Initial Coin Offering (ICO)
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.